At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Stephan Stilgenbauer, MD, of Ulm University, Ulm, Germany, reviews the changing chronic lymphocytic leukaemia (CLL) treatment landscape and the progress of optimising new therapeutic approaches for clinical practice.
An update on the treatment of chronic lymphocytic leukaemia
26th August 2015
Oncology
Related To This Subject
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now